The "second generation" NHLBI Percutaneous Transluminal Coronary Angioplasty Registry. Have we established the role for PTCA in treating coronary artery disease? | Zendy

Michael B. Mock | Zendy; Hugh C. Smith | Zendy; C. J. Mullany | Zendy

Open Access

The "second generation" NHLBI Percutaneous Transluminal Coronary Angioplasty Registry. Have we established the role for PTCA in treating coronary artery disease?

Author(s) -

Michael B. Mock,

Hugh C. Smith,

C. J. Mullany

Publication year - 1989

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.80.3.700

Subject(s) - medicine , percutaneous transluminal coronary angioplasty , cardiology , coronary artery disease , angioplasty , restenosis , percutaneous , artery , stent

T he initial National Heart, Lung, and Blood Institute (NHLBI) Percutaneous Transluminal Coronary Angioplasty (PTCA) registry was established when the technique was in its infancy. The initial PTCA registry had the strong endorsement and support of the innovator of coronary angioplasty, Dr. Andreas Gruentzig.1 The registry tracked the early experience and development of this innovative technique from 1977 to 1981. The goals of the founders of the registry were to define appropriate patients for the procedure and evaluate early success, complication rates, and late followup. It was anticipated that the registry data would be used to design a controlled clinical trial to

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research